TNF Alpha & IL-2 Expressing Oncolytic Adenovirus to Enable T-cell Therapies
Time: 2:10 pm
day: Day One
Details:
• How using an oncolytic virus can overcome some of the limitations of T-cell therapy
• How the treatments induce immune changes in tumor and blood of patients
• How the approach results in immunotherapy naïve patients vs those that progressed upon immunotherapy
